AI assistant
SOLESENCE, INC. — Director's Dealing 2006
Jul 5, 2006
33563_dirs_2006-07-05_bf4e7a37-b801-4a7c-b15a-9fcb03334cc7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2006-07-03
Reporting Person: HENDERSON JAMES A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-07-03 | Deferred Common Stock | $ | A | 852 | Acquired | Common Stock (852) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8410 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $8.57 | 2011-07-17 | Common Stock (10000) | 10000 | Direct |
| Stock Option (right to buy) | $3.78 | 2012-11-25 | Common Stock (2000) | 2000 | Direct |
| Stock Option (right to buy) | $5.07 | 2013-06-26 | Common Stock (2000) | 2000 | Direct |
Footnotes
F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
F2: 852 shares of common stock were to be granted under the Company's 2005 Non-Employee Director Restricted Stock Plan. Such shares are vested immediately but subject to certain transfer restrictions. Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive instead 852 shares of deferred common stock which, along with the 1,895 similar shares granted previously, will be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
F3: Each share of deferred common stock represents a right to receive one share of common stock.
F4: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F5: Pursuant to such plan, the reporting person elected to defer receipt of such shares and recieve 852 shares of deferred common stock, amounting to a cumulative total of 2,747 shares of deferred common stock received (including those received from previous grants) to date, which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.